First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries-Reference-Cited by-同舟云学术

First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries

Published:2013-10-11 Issue:10 Volume:8 Page:e76765
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hillemann Doris,Hoffner Sven,Cirillo Daniela,Drobniewski Francis,Richter Elvira,Rüsch-Gerdes Sabine, , ,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard;GL Woods;NCCLS,2003

2. Barrera L, Cooreman E, de Dieu Iragena J, Drobniewski F, Duda P, et al.. (2008) Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. WHO/HTM/TB/2008.392.

3. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis;M Garrigó;J Clin Microbiol,2007

4. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system;GE Pfyffer;J Clin Microbiol,2002

5. Multicenter evaluation of the mycobacterial growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs;S Rüsch-Gerdes;J Clin Microbiol,1999

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proficiency of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China, 2008–2021;PLOS ONE;2024-05-29

2. Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study;Antimicrobial Agents and Chemotherapy;2022-06-21

3. Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia;PLOS ONE;2022-06-09

4. Rare alternative second line injectable drug resistance markers identified by gene-wise genome wide association in M. tuberculosis with unexplained resistance;2021-11-24

5. Hyperpolarized 13 C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco;NMR in Biomedicine;2020-03-19